Sexual Health & Libido Restoration
PT-141 is Vyleesi for premenopausal HSDD. Kisspeptin is upstream GnRH biology. This page maps the SKUs. It is not a PDE5 and not a general ED or libido NDA.
Duration
As needed or cyclical
First reports
Within 2-6 hours (PT-141)
SKUs on this map
2
1Overview
RECONNECT (n=1,247) is the Vyleesi file: desire scores and distress in premenopausal HSDD. Effects start hours after a labeled 1.75 mg SC dose. Nausea is common. Max 8 doses/month. Compounded PT-141 is not Vyleesi. Male ED use is off-label. Kisspeptin is academic GnRH work, not an FDA sexual-health product.
Ideal Candidates
Contraindications
2The Science
PDE5 inhibitors work on blood flow. Bremelanotide (Vyleesi) is an MC3R/MC4R agonist labeled for acquired, generalized HSDD in premenopausal women. That is a CNS desire label, not a general ED NDA and not a research-chem cake. Kisspeptin sits upstream of GnRH. Imperial College imaging work is not a kisspeptin-10 vial protocol.
3Clinical Evidence
Key Findings
Bremelanotide 1.75mg SC: statistically significant increase in sexual desire scores and decrease in distress in premenopausal women with HSDD
RECONNECT Phase 3 trials, n=1,247
FDA approved Vyleesi (bremelanotide) in June 2019 for acquired, generalized HSDD in premenopausal women
FDA approval
Most common side effect: nausea (~40% of patients in trials), typically decreasing with subsequent doses
RECONNECT safety data
Transient increases in blood pressure and decreases in heart rate observed post-dose; contraindicated in uncontrolled hypertension
FDA prescribing information
Kisspeptin infusion enhances brain activity in regions processing sexual and emotional stimuli in healthy men
Imperial College London, Dhillo et al.
Focal hyperpigmentation reported with repeated use, particularly in darker-skinned patients
Post-marketing surveillance
Study Limitations
- ⚠Vyleesi FDA approval is specifically for premenopausal women with acquired HSDD; use in men is off-label
- ⚠Maximum recommended frequency: 1 dose/24 hours, 8 doses/month to limit cardiovascular effects
- ⚠If no benefit after 8 weeks of use, discontinuation is recommended per FDA labeling
- ⚠Kisspeptin human sexual health data is primarily from academic research settings; not yet approved for clinical use
- ⚠Compounded PT-141 products may vary significantly from the FDA-approved Vyleesi formulation in purity, sterility, and dosing
4The Peptide Stack
PT-141
View Profile →FDA-approved as Vyleesi for acquired, generalized HSDD in premenopausal women. RECONNECT (n=1,247) is that file. A research cake is not the labeled product.
Mechanism: MC3R/MC4R agonist in hypothalamus. Different from PDE5. That difference is pharmacology, not a guarantee that off-label male use works.
Kisspeptin
View Profile →KISS1R agonist upstream of GnRH. Academic infusion papers exist. Not a TRT replacement and not Vyleesi.
Mechanism: Activates KISS1R on GnRH neurons. Pulsatile use is the biology. Continuous exposure downregulates. A research vial is not a fertility protocol on this site.
5Protocol Tiers
On-Demand Arousal
Labeled Vyleesi is as-needed. Compounded cakes are not that product. Max 8 doses/month on the label.
Hormonal Baseline Restoration
Kisspeptin as GnRH biology. Not a neuroendocrine-suppression treatment and not a libido NDA.
6Lifestyle Integration
Lifestyle notes that travel with these SKUs. Not a prescription and not required for the math to be valid.
Training
Heavy resistance training naturally upregulates testosterone and androgen receptor density; however, severe overtraining crashes libido instantly.
Nutrition
Prioritize adequate cholesterol intake, as cholesterol is the essential precursor molecule for all steroidal sex hormones, including testosterone.
Sleep
Poor sleep destroys testosterone profiles. REM sleep is critical for morning erections and psychogenic desire.
Stress Management
Cortisol actively suppresses testosterone production; severe psychological stress completely overrides the HPG axis, killing libido even if peptides are used.
7Timeline & Expectations
Hours 2-6 (PT-141)
Weeks 2-4 (Kisspeptin)
8Monitoring & Safety
Key Metrics to Track
Troubleshooting
Severe Nausea from PT-141
- Dose too high initially
- Sensitive melanocortin response
- Drop dose to 0.5mg
- Take an anti-nausea medication or ginger root 30 mins prior
- Take right before a brief nap; nausea usually passes in 30 mins while arousal lasts for hours
No physical response
- Timing misalignment
- Under-dosing
- PT-141 peaks much later than Viagra (often 4-8 hours later); adjust administration timing.
9Further Reading
Dive deeper into the individual peptides and methodologies behind this protocol.
PT-141 (Bremelanotide) Dosage Guide: The Sexual Health Peptide for Men and Women
PT-141 dosage guide for men and women - melanocortin mechanism, FDA-approved dose, reconstitution math, and free calculator.
Read article →PT-141 (Bremelanotide): How the First Brain-Based Aphrodisiac Works
PT-141 is not Viagra. It does not increase blood flow. It activates melanocortin-4 receptors in the brain to generate genuine sexual arousal. Mechanism, dosing, FDA approval, and clinical data.
Read article →Best Peptides for Women Over 40: Menopause, Fat Loss, Sleep & Skin
Evidence-based guide to peptides for women over 40 - menopause weight gain, sleep disruption, skin aging, libido, and which peptides address each.
Read article →